Hyperdense Middle Cerebral Artery Sign as a Predictor of First-Pass Recanalization and Favorable Outcomes in Direct Thrombectomy Patients
Clinical Neuroradiology · 2025
DOI: 10.1007/s00062-024-01484-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Neuroradiology, 2025. Verfasst von Yiyang Sun und 10 weiteren Autor:innen. Beteiligte Einrichtung: Interventional Neuroradiology, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, No.119 South 4th Ring West Road, 100070…. Hauptthemen laut MEDLINE: Thrombectomy, Infarction, Middle Cerebral Artery, Middle Cerebral Artery. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Sanofi China Investment Company.
Abstract (Originalsprache)
BACKGROUND: The Hyperdense Middle Cerebral Artery Sign (HMCAS) is an early marker of acute MCA occlusion on non-contrast CT (NCCT), which has been linked with stroke type and thrombus composition. AIMS: To assess the prognostic value of HMCAS in M1 occlusion patients treated with endovascular thrombectomy and explore its predictive value across different patients. METHODS: Patients with M1 occlusion were selected from the ANGEL-ACT registry, which comprised 1793 individuals. Cohorts were divided based on the presence of HMCAS. The primary outcome was functional independence (mRS 0-2) at 90 days. Secondary outcomes included excellent outcome (mRS 0-1), good functional outcome (mRS 0-3), modified first pass effect (mFPE), successful recanalization, intracranial hemorrhage, and 90-day mortality. Propensity score matching (PSM) was employed to adjust for confounders, with 96 patients in each matched group. Subgroup analysis was performed to determine whether the effect of HMCAS on clinical outcomes differed between groups. RESULTS: Among 714 acute M1 occlusion patients, 96 (13.4%) had HMCAS. PSM analysis showed that HMCAS was independently associated with mFPE (OR: 1.97, 95% CI: 1.04-3.75, p = 0.038) but had no significant effects on other clinical outcomes. There was a significant association between HMCAS and functional independence for patients who underwent direct thrombectomy but not for patients who underwent bridging therapy (P for interaction = 0.033). CONCLUSION: This study indicates that in patients with acute M1 occlusion undergoing EVT, HMCAS on pretreatment NCCT is not significantly associated with functional independence but is linked to a higher first-pass recanalization rate. Its clinical impact on outcomes depends on whether intravenous thrombolysis is administered before thrombectomy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Interventional Neuroradiology, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, No.119 South 4th Ring West Road, 100070, Fengtai District, Beijing, China.
- Cerebrovascular Disease Department, Neurological Disease Center, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
- China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
- Interventional Neuroradiology, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, No.119 South 4th Ring West Road, 100070, Fengtai District, Beijing, China. zhongrongm@163.com.
Förderung
- Sanofi China Investment Company
Zitieren
APA
Sun, Y., Sun, D., Jia, B., Huo, X., Tong, X., Wang, A., Ma, N., Gao, F., Mo, D., Miao, Z., & ANGEL-ACT study group (2025). Hyperdense Middle Cerebral Artery Sign as a Predictor of First-Pass Recanalization and Favorable Outcomes in Direct Thrombectomy Patients. Clinical Neuroradiology. https://doi.org/10.1007/s00062-024-01484-2
Vancouver
Sun Y, Sun D, Jia B, Huo X, Tong X, Wang A, et al. Hyperdense Middle Cerebral Artery Sign as a Predictor of First-Pass Recanalization and Favorable Outcomes in Direct Thrombectomy Patients. Clinical Neuroradiology. 2025. doi:10.1007/s00062-024-01484-2
BibTeX
@article{Sun2025,
author = {Sun, Yiyang and Sun, Dapeng and Jia, Baixue and Huo, Xiaochuan and Tong, Xu and Wang, Anxin and Ma, Ning and Gao, Feng and Mo, Dapeng and Miao, Zhongrong and ANGEL-ACT study group, ANGEL-ACT study group},
title = {Hyperdense Middle Cerebral Artery Sign as a Predictor of First-Pass Recanalization and Favorable Outcomes in Direct Thrombectomy Patients},
journal = {Clinical Neuroradiology},
year = {2025},
doi = {10.1007/s00062-024-01484-2}
}
EUVIMED